azacitidine and Neuroectodermal Tumors, Primitive

azacitidine has been researched along with Neuroectodermal Tumors, Primitive in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clifford, SC; Farwick, N; Frühwald, MC; Gerss, J; Hasselblatt, M; Kerl, K; Kreth, JH; Lechtape, B; Mühlisch, J; Plagemann, T; Richter, GH; Schlosser, S; Unland, R1
Frühwald, MC; Grotzer, M; Hagemann, C; Jürgens, H; Mühlisch, J; Osada, N; Rickert, CH; Roggendorf, W; Schwering, A; Sörensen, N; Vince, GH1
Brodeur, GM; Eggert, A; Grotzer, MA; Ikegaki, N; Janss, AJ; Marwaha, S; Phillips, PC; Wiewrodt, BR; Zuzak, TJ1

Other Studies

3 other study(ies) available for azacitidine and Neuroectodermal Tumors, Primitive

ArticleYear
Epigenetic repression of the dopamine receptor D4 in pediatric tumors of the central nervous system.
    Journal of neuro-oncology, 2014, Volume: 116, Issue:2

    Topics: Apoptosis; Azacitidine; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Central Nervous System Neoplasms; Child; Chromatin Assembly and Disassembly; Decitabine; Dose-Response Relationship, Drug; Epigenesis, Genetic; Female; Humans; Hydroxamic Acids; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Receptors, Dopamine D4; Sulfites; Tumor Cells, Cultured

2014
Epigenetic repression of RASSF1A but not CASP8 in supratentorial PNET (sPNET) and atypical teratoid/rhabdoid tumors (AT/RT) of childhood.
    Oncogene, 2006, Feb-16, Volume: 25, Issue:7

    Topics: Adolescent; Adult; Azacitidine; Brain Neoplasms; Caspase 8; Caspases; Child; Child, Preschool; CpG Islands; Decitabine; DNA Methylation; Epigenesis, Genetic; Female; Gene Silencing; Humans; Hydroxamic Acids; Infant; Male; Neuroectodermal Tumors, Primitive; Promoter Regions, Genetic; Rhabdoid Tumor; Teratoma; Tumor Suppressor Proteins

2006
Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression.
    Oncogene, 2000, Sep-21, Volume: 19, Issue:40

    Topics: Adult; Antimetabolites, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Azacitidine; Carrier Proteins; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 8; Caspase 9; Caspases; Child; Cycloheximide; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Drug Resistance; Enzyme Induction; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; Jurkat Cells; Membrane Glycoproteins; Neoplasm Proteins; Neuroectodermal Tumors, Primitive; Protein Synthesis Inhibitors; Receptors, Tumor Necrosis Factor; Recombinant Proteins; RNA, Messenger; RNA, Neoplasm; TNF-Related Apoptosis-Inducing Ligand; Transcription, Genetic; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

2000